CN101210015A - 一种乙肝治疗药物恩替卡韦的制备方法 - Google Patents
一种乙肝治疗药物恩替卡韦的制备方法 Download PDFInfo
- Publication number
- CN101210015A CN101210015A CNA2006101305657A CN200610130565A CN101210015A CN 101210015 A CN101210015 A CN 101210015A CN A2006101305657 A CNA2006101305657 A CN A2006101305657A CN 200610130565 A CN200610130565 A CN 200610130565A CN 101210015 A CN101210015 A CN 101210015A
- Authority
- CN
- China
- Prior art keywords
- preparation
- compound
- entecavir
- methyl
- anhydrous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101305657A CN101210015B (zh) | 2006-12-26 | 2006-12-26 | 一种乙肝治疗药物恩替卡韦的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101305657A CN101210015B (zh) | 2006-12-26 | 2006-12-26 | 一种乙肝治疗药物恩替卡韦的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101210015A true CN101210015A (zh) | 2008-07-02 |
CN101210015B CN101210015B (zh) | 2010-09-22 |
Family
ID=39610284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101305657A Expired - Fee Related CN101210015B (zh) | 2006-12-26 | 2006-12-26 | 一种乙肝治疗药物恩替卡韦的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101210015B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101805339A (zh) * | 2010-04-12 | 2010-08-18 | 王明 | 一种新方法的恩替卡韦化合物 |
CN102002023A (zh) * | 2010-10-20 | 2011-04-06 | 湖南欧亚生物有限公司 | 恩替卡韦中间体的制备方法 |
CN101723945B (zh) * | 2008-10-17 | 2011-11-02 | 上海清松制药有限公司 | 一种制备抗病毒药物恩替卡韦中间体的方法 |
CN101693713B (zh) * | 2009-10-28 | 2011-11-09 | 福建广生堂药业有限公司 | 一种恩替卡韦的晶型及其制备方法和药物应用 |
US8569490B2 (en) | 2008-12-26 | 2013-10-29 | Hanmi Science Co., Ltd | Intermediate and process for preparing entecavir using same |
CN107400135A (zh) * | 2017-07-12 | 2017-11-28 | 浙江华圣生物药业有限公司 | 一种恩替卡韦中间体的处理方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206244A (en) * | 1990-10-18 | 1993-04-27 | E. R. Squibb & Sons, Inc. | Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines |
US7511139B2 (en) * | 2004-06-04 | 2009-03-31 | Bristol-Myers Squibb Company | Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
-
2006
- 2006-12-26 CN CN2006101305657A patent/CN101210015B/zh not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101723945B (zh) * | 2008-10-17 | 2011-11-02 | 上海清松制药有限公司 | 一种制备抗病毒药物恩替卡韦中间体的方法 |
US8569490B2 (en) | 2008-12-26 | 2013-10-29 | Hanmi Science Co., Ltd | Intermediate and process for preparing entecavir using same |
CN101693713B (zh) * | 2009-10-28 | 2011-11-09 | 福建广生堂药业有限公司 | 一种恩替卡韦的晶型及其制备方法和药物应用 |
CN101805339A (zh) * | 2010-04-12 | 2010-08-18 | 王明 | 一种新方法的恩替卡韦化合物 |
CN102002023A (zh) * | 2010-10-20 | 2011-04-06 | 湖南欧亚生物有限公司 | 恩替卡韦中间体的制备方法 |
CN107400135A (zh) * | 2017-07-12 | 2017-11-28 | 浙江华圣生物药业有限公司 | 一种恩替卡韦中间体的处理方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101210015B (zh) | 2010-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101210015B (zh) | 一种乙肝治疗药物恩替卡韦的制备方法 | |
CN102336754B (zh) | 恩替卡韦的合成方法及其中间体化合物 | |
CN104817593B (zh) | 半富马酸替诺福韦艾拉酚胺关键中间体的合成工艺 | |
CN103304375B (zh) | 恩替卡韦的合成中间体及其制备方法 | |
CN103664912B (zh) | 一种普卡必利的合成工艺 | |
CN102143967B (zh) | 阿德福韦酯的纯化方法 | |
CN102477036A (zh) | 一种制备恩替卡韦一水合物的方法 | |
CN113527303B (zh) | 一种瑞德西韦母核中间体的制备工艺 | |
US8658792B2 (en) | Carbanucleoside synthesis and novel intermediate compounds useful therein | |
CN102417506B (zh) | 一种抗病毒药物恩替卡韦的制备方法 | |
CN101130542B (zh) | 抗病毒核苷类似物的合成方法 | |
CN102225938A (zh) | 恩替卡韦一水合物新合成工艺 | |
CN108148061B (zh) | 恩替卡韦的工业化制备方法 | |
CN104918924B (zh) | 制备氟代内酯衍生物的方法 | |
CN106496220B (zh) | 一种麦角醇的制备方法 | |
CN101838270B (zh) | 恩替卡韦的中间体及制备 | |
CN101838207B (zh) | 恩替卡韦的中间体及合成方法 | |
CN109678787A (zh) | 一种新的hcv病毒ns3/4a抑制剂合成中间体及合成方法 | |
CN112390816B (zh) | 氧氮杂卓类化合物的制备方法 | |
CN108203435B (zh) | 一种利用Boc保护基的恩替卡韦的制备方法 | |
CN111320588B (zh) | 一种纯化Lesinurad的方法 | |
CN106496208A (zh) | 恩曲他滨的制备方法 | |
CN101863842B (zh) | 恩替卡韦中间体及合成方法 | |
CN101830856A (zh) | 恩替卡韦中间体及制备 | |
CN107304194A (zh) | 制备达格列净的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI GUOCHUANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HANGZHOU SHENGYOU MEDICINE TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20100504 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310012 ROOM 805, QIANJIANGKEJI BUILDING, NO.388, WEN 3RD ROAD, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 201203 ROOM 305-17, NO.665, ZHANGJIANG ROAD, PUDONG NEW DISTRICT, SHANGHAI CITY, SHANGHAI CITY |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100504 Address after: 201203, room 665, 305-17 Zhangjiang Road, Shanghai, Shanghai, Pudong New Area Applicant after: Hangzhou Shengyou Medicine Technology Development Co., Ltd. Co-applicant after: Tianjin Taipu Pharmaceutical Science & Technology Development Co., Ltd. Address before: 805 room 310012, Qianjiang science and technology building, No. 388, Wensanlu Road, Zhejiang, Hangzhou Applicant before: Hangzhou Shengyou Medicine Technology Development Co., Ltd. Co-applicant before: Tianjin Taipu Pharmaceutical Science & Technology Development Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100922 Termination date: 20181226 |
|
CF01 | Termination of patent right due to non-payment of annual fee |